The Food and Drug Administration (FDA) held a public meeting in September 2014, where people living with idiopathic pulmonary fibrosis (IPF) were asked about the daily effects of the disease and the therapies that were available to them.
One of the main themes of the meeting was how coughing affected people living with the condition. More than three-quarters of people attending the meeting said that coughing had a significant effect on their daily lives, with patients reporting episodes of violent coughing, uncontrollable coughing, coughing with thick sticky mucus, and some patients explained that their coughing fits led to shortness of breath, hypoxia, chest and rib pain, sleeping difficulties, and exhaustion.
For the majority of IPF patients, the coughing was usually triggered by one of the following four events:
Many patients reported that physical activity associated with everyday tasks such as housework, climbing stairs, walking, showering, getting dressed and other activities that led to shortness of breath brought on coughing episodes.